To determine whether HWJMSCs /IGF-1 transplantation can reduce the myocardial ischemia severity and improve myocardial perfusion and function, SPECT and echocardiography were used 8 weeks after treatment. The gene discussed is IGF1; the disease is myocardial ischemia.